Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model

Author:

Lyman Daniel F12ORCID,Bell Amanda12,Black Alyson345,Dingerdissen Hayley12ORCID,Cauley Edmund126,Gogate Nikhita12,Liu David7,Joseph Ashia12,Kahsay Robel12,Crichton Daniel J7,Mehta Anand6,Mazumder Raja126

Affiliation:

1. School of Medicine & Health Sciences The Department of Biochemistry and Molecular Medicine, Ross Hall, , , 2300 Eye Street N.W., Washington, DC 20037 , USA

2. The George Washington University The Department of Biochemistry and Molecular Medicine, Ross Hall, , , 2300 Eye Street N.W., Washington, DC 20037 , USA

3. The McCormick Genomic and Proteomic Center , The Department of Biochemistry and Molecular Medicine, Ross Hall, , , 2300 Eye Street N.W., Washington, DC 20037 , USA

4. School of Medicine & Health Sciences , The Department of Biochemistry and Molecular Medicine, Ross Hall, , , 2300 Eye Street N.W., Washington, DC 20037 , USA

5. The George Washington University , The Department of Biochemistry and Molecular Medicine, Ross Hall, , , 2300 Eye Street N.W., Washington, DC 20037 , USA

6. The Medical University of South Carolina The Department of Cell & Molecular Pharmacology, Basic Science Building 358, 173 Ashley Avenue, , Charleston, SC 29425 , USA

7. NASA Jet Propulsion Laboratory , 4800 Oak Grove Dr., Pasadena, California 91109 , USA

Abstract

Abstract Molecular biomarkers measure discrete components of biological processes that can contribute to disorders when impaired. Great interest exists in discovering early cancer biomarkers to improve outcomes. Biomarkers represented in a standardized data model, integrated with multi-omics data, may improve the understanding and use of novel biomarkers such as glycans and glycoconjugates. Among altered components in tumorigenesis, N-glycans exhibit substantial biomarker potential, when analyzed with their protein carriers. However, such data are distributed across publications and databases of diverse formats, which hamper their use in research and clinical application. Mass spectrometry measures of 50 N-glycans on 7 serum proteins in liver disease were integrated (as a panel) into a cancer biomarker data model, providing a unique identifier, standard nomenclature, links to glycan resources, and accession and ontology annotations to standard protein, gene, disease, and biomarker information. Data provenance was documented with a standardized United States Food and Drug Administration-supported BioCompute Object. Using the biomarker data model allows the capture of granular information, such as glycans with different levels of abundance in cirrhosis, hepatocellular carcinoma, and transplant groups. Such representation in a standardized data model harmonizes glycomics data in a unified framework, making glycan–protein biomarker data exploration more available to investigators and to other data resources. The biomarker data model we describe can be used by researchers to describe their novel glycan and glycoconjugate biomarkers; it can integrate N-glycan biomarker data with multi-source biomedical data and can foster discovery and insight within a unified data framework for glycan biomarker representation, thereby making the data FAIR (Findable, Accessible, Interoperable, Reusable) (https://www.go-fair.org/fair-principles/).

Funder

NIH

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Biochemistry

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3